Followers | 493 |
Posts | 30537 |
Boards Moderated | 3 |
Alias Born | 01/31/2008 |
Sunday, March 31, 2024 1:55:33 PM
Glooko’s solutions aided over 3.4 million people with diabetes and are utilized in nearly 5,000 clinic locations.1
All posts are my opinion and are not recommendations to buy or sell
Recent BTTX News
- Better Therapeutics Announces it will Seek Strategic Alternatives and will be Delisted from Nasdaq • Business Wire • 03/14/2024 01:38:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/11/2024 01:01:07 PM
- Better Therapeutics Announces an Innovative Partnership with the American College of Lifestyle Medicine to Expand Access to AspyreRx Across 1,400 Federally Qualified Health Centers • Business Wire • 03/05/2024 02:25:00 PM
- Better Therapeutics Announces Acceptance of Late Breaking Abstract for Its AspyreRx Pivotal Trial 180 Day Outcomes and Participation at the 17th International Conference on Advanced Technologies & Treatments for Diabetes (ATTD) • Business Wire • 03/04/2024 02:25:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/04/2024 01:51:02 PM
- Form RW - Registration Withdrawal Request • Edgar (US Regulatory) • 03/01/2024 11:08:59 AM
- Better Therapeutics Receives FDA Breakthrough Device Designation for Digital Therapeutic Platform Targeting Advanced Liver Disease • Business Wire • 02/20/2024 02:25:00 PM
- Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] • Edgar (US Regulatory) • 02/12/2024 09:28:28 PM
- Better Therapeutics Signs Rebate Agreement with One of the Largest Pharmacy Benefit Managers in the US for its AspyreRx Diabetes Treatment • Business Wire • 02/06/2024 02:43:00 PM
- Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 02/06/2024 02:02:40 PM
- Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] • Edgar (US Regulatory) • 01/25/2024 09:30:59 PM
- Form D - Notice of Exempt Offering of Securities • Edgar (US Regulatory) • 01/23/2024 10:22:26 PM
- Better Therapeutics Announces Publication of Cost-Effectiveness Analysis Demonstrating AspyreRx is More Effective and Less Costly than Standard of Care Alone • Business Wire • 01/17/2024 02:28:00 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 01/10/2024 12:01:06 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/08/2024 09:42:54 PM
- Better Therapeutics and Glooko Announce Partnership to Accelerate Adoption of AspyreRx to Treat Type 2 Diabetes in the United States • Business Wire • 01/04/2024 07:00:00 PM
- Better Therapeutics Announces Submission for FDA Breakthrough Device Designation for Digital Therapeutic Platform to Treat Liver Disease • Business Wire • 01/02/2024 12:45:00 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 12/29/2023 02:23:11 AM
- Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 12/21/2023 10:21:59 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/20/2023 10:23:04 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/20/2023 10:21:56 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/20/2023 10:10:07 PM
- Form S-1 - General form for registration of securities under the Securities Act of 1933 • Edgar (US Regulatory) • 12/13/2023 10:24:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/13/2023 10:06:53 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM